锦欣生殖：截至2025年12月31日止年度的业绩公告

1951Jinxin Fertility Group Limited* 20251231 •202512312,649.1202412312,811.65.8% •20251231983.920241231273.520251231976.120241231283.1 •20251231(1)209.320241231416.349.7%20251231EBITDA(2)682.820241231EBITDA628.8202512 31EBITDA(3)491.120241231EBITDA707.330.6% •202512 310.36202512 31(4)0.08 •202512314.1820241231 EBITDAEBITDA (1)(i)(ii)(iii)(iv)(v)IOT(vi) (2)EBITDA (3)EBITDAEBITDA(i)(ii)(iii)(iv)IOT (4) 20251231 202512312024 20252024 32,649,0732,811,596(1,762,532)(1,712,142) 20252024 (976,146)283,099(7,739)(9,632) (983,885)273,467 (1,068,668)337,199(8,590)(8,892) (1,077,258)328,307 202512 31 20251231 1. 20185 3221961320182019625 (i)(ii)(iii)(iv)(v) 2. 202511 21 21397297210281112183 1220261 1320271 1 18 181118187733 1820271 11818 3. 202520241231 2025202412318 20251231 2024 * *20251231IVF487,443,00010,253,0002024516,349,00028,450,000 15 202512318,880,708,0003,582,390,000202412319,070,095,0004,362,767,000202512 3120241231 10% 20252024 HRC Medical 4. 18 5. 50,000,00020242024119 6. 202161550,000,000202551525,000,0002025123120,000,000202420251231202445,000,000 8. 202512313.40%20243.69%4.97%2024 10. 2025202416.5% 25%15%20081110% 20252024123121%8.84%2025202412 31 202512 31560,924,000202412311,147,074,000 1,822,412,00020241,346,839,000465,835,0002024463,320,000274,306,0002024159,834,000203020242029 11. 20252024 2024202420235.95 202512312026326202512314.183.70100,000,000 2024625202312315.955150,000,000 12. 202520241231 202520241231 20251231976,146,000 13. 20242024 2025630HRC ManagementHRC Management729IVFHRC ManagementHRC Management952,413,0002024HRC Management631,594,000320,819,000HRC Management(i)(ii)(iii)215,556,000105,263,000202420251231HRC Management23,104,000HRC Management202563020251231HRC Management2,110,552,00020243,229,087,000 14. 20231126Xizang Jinli Enterprise Management Co., Ltd.WP Healthcare Investment (Wuxi Yixing) Partnership (Limited Partnership)WPPartnership7.52%200,000,0002024123180,000,000 202511 17WP Partnership82,062,000202512312,062,000620251231202480,000,000 15. 2025123148,627,000202412,157,00036,470,0002025123135,676,000202484,303,000 16. iii ii i.20221212025113043,300,00040,100,000202512 31 ii.3,205,00022,526,00020243,115,00022,391,000IVF Universal, LLC955,0006,712,0002024938,0006,742,0002024 20241 173,086,000 90202490 HRC Management60365 60180 202420251231 9091180180 (i)202224202512 31202412 31 (ii) 3090 9091180181365365 19. 202512313,121,013,00020243,294,476,0002,927,397,00020243,183,799,000202512314.36%20245.87%202620342024123120252034 202512 31(i)(ii) SAC Insight202531.562032104.6618.7% 20192025800 20253435.735PGT 2026211676.3202410.76% 202520162025202318.2%202054.8202560.62030203567.474.4 ARS12025ARS10.5%36.5%34.5%ARSARS 2026 •47 • • •202512 1 2021 202282025331ARS2024ARS 20247 20241041320241127202412112025 2025 20253 7 20253 1310,00050,000100,000 20257202511332025113 IOTMSAIOT/MSA (1)IOT/MSAIOT/MSA2025497.72024544.8 (2) (3)SB 72920261(IVF)HRC FertilitySB 729100(OPU) HRC Fertility2025HRC Fertility2025Beverly Hills 20246.1%IUI3202462202413,8841.3%202514,070VIP21.2%20241IUI20241231660202512311,947IUIOPU10.1% 2024IVF2,50020251,58372.8%5CDC50%PGT2024IVF7020||IVF+MDTVIP 2025IUIIUI2025IVF13.8%202416%IUI20245,7695.9%20255,428IUI20241231746202512 311,769IUIOPU10.5%20241231468.88.8%20251231427.6 2026218%40,0004IVFVIP IVFVIPIVF 20259IVFIVF2.7%5.3%20244,2421.5%20254,30620241231265.92.9%202512 31273.7 2-3 5231% 202510.9% SB 729HRC Fertility20245.1% HRC2025(ASP)202411.8% SB 729(IVF)HRCHRC HRC Medical 372Denovo20257HRC Medical202529HRCMedical2025Beverly Hills20259HRC Medical2025 2025HRC MedicalHRC Medical HRC MedicalHRC Medical20252021(USC)HRC MedicalUSC 20255.88IFRSEBITDA4.9EBITDA 2025202512 3111.1323.704.182025EBITDA20%2026-2028EBITDA50%80%20%EBITDA300 HRC IVF/ICSIIVF/ICSI80%ARS3.82027402.8PT Morula IndonesiaMorula40%ARS 20263 2026 Time to deliveryCAPA3F28 (i)(in vitro activation, IVA)(Platelet-Rich Plasma, PRP)(ii)(iii)(iv)(v) 2026IVF3F 2026 ••(PGT)•DNA(MDT)•• • • •IPIP • AI AIAI+EMRCRM AIAI2025 AIAIIVFAI20258718,179AI 202412 312,811.65.8%202512312,649.1(i)ARS122.7(ii)54.6(iii)13.3(iv)1.5(a)OPU1.4%6.5%ARS(b)31.6%(c) 202412311,712.12.9%202512311,762.5(i)HRCMedicalBeverly Hills34.7(ii)36.3(iii)IVF(iv) 202412311,099.519.4%202512 31886.52024123139.1%2025123133.5% 2024123135.120.8%202512 3127.87.3 202412314.92025123156.350.0 202512 316.6 2024123124.716.4%2025123120.6 202412 31175.25.8%20251231165.0 20241231458.08.7%20251231497.7(i)HRC(ii)(iii)(iv)(v)2025 2024123157.423.9%202512 3171.120251231109.720241231122.54.4%1.5 202412 31118.499.2%202512310.973.174.037.5% 20251231983.920241231273.5(i)(ii)(iii)IOT(iv)(v)(i)ARSIUIIVF(ii)(iii)2026 EBITDAEBITDA 20241231416.349.7%20251231209.3 EBITDA20241231707.330.6%20251231491.1 123120252024 (983,885)273,467(1)28,54147,285(2)64,56564,368(3)906,647–(4)99,009–(5)50,000–(6)36,264–(7)8,166(8)–7,052(9)–24,173